Buck AK - Search Results

1

18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.

Buck D, Förschler A, Lapa C, Schuster T, Vollmar P, Korn T, Nessler S, Stadelmann C, Drzezga A, Buck AK, Wester HJ, Zimmer C, Krause BJ, Hemmer B. Buck D, et al. Among authors: buck ak. J Nucl Med. 2012 Aug;53(8):1269-76. doi: 10.2967/jnumed.111.102608. Epub 2012 Jun 27. J Nucl Med. 2012. PMID: 22738927 Free article.

2

Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.

Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, Dziuk K, Gabelmann A, Reske SN, Hetzel M. Schirrmeister H, et al. Among authors: buck ak. J Nucl Med. 2001 Dec;42(12):1800-4. J Nucl Med. 2001. PMID: 11752076 Free article.

3

Initial results in the assessment of multiple myeloma using 18F-FDG PET.

Schirrmeister H, Bommer M, Buck AK, Müller S, Messer P, Bunjes D, Döhner H, Bergmann L, Reske SN. Schirrmeister H, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):361-6. doi: 10.1007/s00259-001-0711-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002711 Clinical Trial.

4

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, Mattfeldt T, Neumaier B, Reske SN, Hetzel M. Buck AK, et al. J Nucl Med. 2003 Sep;44(9):1426-31. J Nucl Med. 2003. PMID: 12960187 Free article. Clinical Trial.

5

Cellular origin and molecular mechanisms of 18F-FDG uptake: is there a contribution of the endothelium?

Buck AK, Reske SN. Buck AK, et al. J Nucl Med. 2004 Mar;45(3):461-3. J Nucl Med. 2004. PMID: 15001688 Free article. No abstract available.

6

Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker?

Buck AK, Glatting G, Reske SN. Buck AK, et al. J Nucl Med. 2004 Aug;45(8):1274-6. J Nucl Med. 2004. PMID: 15299047 Free article. No abstract available.

7

Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.

Krüger S, Buck AK, Blumstein NM, Pauls S, Schelzig H, Kropf C, Schumann C, Mottaghy FM, Hombach V, Reske SN. Krüger S, et al. Among authors: buck ak. J Intern Med. 2006 Dec;260(6):545-50. doi: 10.1111/j.1365-2796.2006.01729.x. J Intern Med. 2006. PMID: 17116005 Free article.

8

Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.

Pauls S, Buck AK, Hohl K, Halter G, Hetzel M, Blumstein NM, Mottaghy FM, Glatting G, Krüger S, Sunder-Plassmann L, Möller P, Hombach V, Brambs HJ, Reske SN. Pauls S, et al. Among authors: buck ak. Nuklearmedizin. 2007;46(1):9-14; quiz N1-2. Nuklearmedizin. 2007. PMID: 17299649

9

Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.

Herrmann K, Wieder HA, Buck AK, Schöffel M, Krause BJ, Fend F, Schuster T, Meyer zum Büschenfelde C, Wester HJ, Duyster J, Peschel C, Schwaiger M, Dechow T. Herrmann K, et al. Among authors: buck ak. Clin Cancer Res. 2007 Jun 15;13(12):3552-8. doi: 10.1158/1078-0432.CCR-06-3025. Clin Cancer Res. 2007. PMID: 17575218

10

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

Krause BJ, Souvatzoglou M, Tuncel M, Herrmann K, Buck AK, Praus C, Schuster T, Geinitz H, Treiber U, Schwaiger M. Krause BJ, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):18-23. doi: 10.1007/s00259-007-0581-4. Epub 2007 Sep 22. Eur J Nucl Med Mol Imaging. 2008. PMID: 17891394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page